Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,495

Procedures

32

Market Approvals

64

Published Papers

47%

reduction in hospital stay20

38%

reduction in donor skin21

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

55%

reduction in wound area in 4 weeks2

33%

pain reduction in one week7

ReGenerCell™ is a medical device that allows medical professionals to swiftly create a suspension of skin cells that can trigger healing in chronic wounds, such as venous leg ulcers and diabetic foot ulcers.

78%

re-pigmentation2

reduced

healing time, risk of infection and scarring4,6,7

ReNovaCell™ is a medical device that delivers a skin cell suspension for treating aesthetic applications: restoring pigmentation, and improving the appearance of scars, sun-damaged skin, wrinkles and lesions.

Twitter

follow

Saturday, March 25th, 2017 at 2:23am
Great discussion and questions on ReCell during ABA correlative session #ameriburn2017
1
Friday, March 24th, 2017 at 10:19am
Adam Kelliher, CEO to present at 16th Annual Needham Healthcare Conference, 4 April, NYC. Register for webcast - https://t.co/x3QxChIZuM
1
2
Friday, March 24th, 2017 at 6:51am
Looking forward to presentation on ReCell tomorrow by Dr. James H. Holmes of Wake Forest Medical Center #ameriburn2017
1
3
Friday, March 24th, 2017 at 6:49am
Interesting ReCell experience presented by Dr. F. Sander from Unfallkrankenhaus, Berlin at #ameriburn2017
2
Wednesday, March 22nd, 2017 at 11:50pm
Excited to be part of the dialogue at the 49th American Burn Association Annual Meeting in Boston, MA March 21-24 #ameriburn2017
1
1

Facebook

follow

Avita Medical
Avita MedicalFriday, March 24th, 2017 at 1:20pm

Adam Kelliher, CEO to present at the 16th Annual Needham Healthcare Conference on 4 April 2017, in NYC. Register to access the webcast of the presentation - http://wsw.com/webcast/needham80/avh

Avita Medical
Avita MedicalFriday, March 17th, 2017 at 3:44pm

Fiona Wood & Suzanne Rea, WA Burns Surgeons, flying high in this month's QANTAS magazine.

Share Price

Last Trade: 0.095 Last Trade: 1.54
High: 0.100 High: 1.55
Low: 0.095 Low: 1.54
Close: 0.095 Close: 1.54
Volume: 251,869 Volume: 2167
Prices are delayed by 20 minutes